In our series the case with non‐germline, persistent high VAF TP53 variants in ctDNA concordant in both initial DLBCL tissue and later HL, TP53 could not be used for the purposes of EMR or MRD monitoring. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.